Humiome® Postbiotics publications

Driving new research

Scientific research is key to our product offerings. We have over 20 years of experience in performing clinical trials and post-marketing studies, engaging in international, multidisciplinary collaborations across the globe to help build knowledge around our product concepts. Explore publications that support Humiome® Postbiotics below.

Effectiveness and Safety of Lactobacillus LB in the Treatment of Mild Acute Diarrhea in Children

Eduardo Salazar-Lindo, Dante Figueroa-Quintanilla, Maria Isabel Caciano, Victoria Reto-Valiente, Gilles Chauviere, Patrick Colin
J Pediatr Gastroenterol Nutr. 2007 May;44(5): 571-6

An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea

Vanessa Liévin-Le Moal, Luis E Sarrazin-Davila, Alain L Servin
Pediatrics, 2007 Oct;120(4): e795-803

Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea

Shu-Dong Xiao, De Zhong Zhang, Hong Lu, Shi Hu Jiang, Hou Yu Liu, Geng Sheng Wang, Guo Ming Xu, Zhong Bing Zhang, Geng Jin Lin, Guo Liang Wang
Adv Ther. 2003 Sep-Oct;20(5): 253-60

The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome

A L Tarrerias, V Costil, F Vicari, J C Létard, P Adenis-Lamarre, A Aisène, D Batistelli, G Bonnaud, S Carpentier, P Dalbiès, S Ecuer, J Etienne, M Fantoli, B Grunberg, P Lannoy, J Lapuelle, A Margulies, M Neumeier, J M Rouillon, L Schmets, M P Pingannaud, P Coulom, F Kholer, J M Canard
Dig Dis. 2011;29(6): 588-91, doi: 10.1159/000332987

Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children

N Simakachorn, V Pichaipat, P Rithipornpaisarn, C Kongkaew, P Tongpradit, W Varavithya
J Pediatr Gastroenterol Nutr. 2000 Jan;30(1): 68-72

Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial

G M Halpern, T Prindiville, M Blankenburg, T Hsia, M E Gershwin
Am J Gastroenterol, 1996 Aug;91(8): 1579-85

Related articles
  • 5 global health priorities creating opportunities for nutritional supplement innovation

    5 global health priorities creating opportunities for nutritional supplement innovation

    Discover how global health concerns reveal where human nutrition and wellness dietary supplement innovations can make the biggest impact.

  • Probiotics for IBS—what’s next? Explore the potential of synbiotics and microencapsulated butyrate with leading gut health scientist

    Probiotics for IBS—what’s next? Explore the potential of synbiotics and microencapsulated butyrate with leading gut health scientist

    New clinical research reveals that a combination of synbiotics and microencapsulated butyrate can improve IBS symptoms in just four weeks.

  • The gut microbiome as a pathway to supporting children with autism: New study reveals synbiotics' dual benefits for digestive and behavioral symptoms

    The gut microbiome as a pathway to supporting children with autism: New study reveals synbiotics' dual benefits for digestive and behavioral symptoms

    Discover new clinical evidence highlighting the potential of synbiotic supplementation in autism spectrum disorder (ASD).

How can we help you?

  • New partnership request

    Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.

翻訳に関する免責事項 このページはAIを使用して自動翻訳されています。正確性を期しておりますが、翻訳に不備があったり、原文の内容が正しく反映されていない場合があります。重要な情報については、原語版をご参照ください。AI翻訳のご利用は、ご自身の責任において行ってください。dsm-firmenichは、これらの翻訳に起因する誤りや誤解について一切の責任を負いません。